S&P 500   3,971.27
DOW   32,394.25
QQQ   307.12
Walgreens Boots Alliance: Blue Chip, High-Yield Turnaround Story
Modern Day Options Trading For Beginners! (Ad)pixel
3 Small Financial Software Makers Showing Strong Chart Action
Roku And The 20% Rally That’s About To Start 
Modern Day Options Trading For Beginners! (Ad)pixel
Here’s Why Viking Therapeutics Rose Over 50% on Obesity Drug Data
Don't Be Fooled by These 3 Value Traps
Modern Day Options Trading For Beginners! (Ad)pixel
The Bottom Is In For McCormick & Company
Interactive Brokers: A Better Bet Than Schwab Post-SVB?
S&P 500   3,971.27
DOW   32,394.25
QQQ   307.12
Walgreens Boots Alliance: Blue Chip, High-Yield Turnaround Story
Modern Day Options Trading For Beginners! (Ad)pixel
3 Small Financial Software Makers Showing Strong Chart Action
Roku And The 20% Rally That’s About To Start 
Modern Day Options Trading For Beginners! (Ad)pixel
Here’s Why Viking Therapeutics Rose Over 50% on Obesity Drug Data
Don't Be Fooled by These 3 Value Traps
Modern Day Options Trading For Beginners! (Ad)pixel
The Bottom Is In For McCormick & Company
Interactive Brokers: A Better Bet Than Schwab Post-SVB?
S&P 500   3,971.27
DOW   32,394.25
QQQ   307.12
Walgreens Boots Alliance: Blue Chip, High-Yield Turnaround Story
Modern Day Options Trading For Beginners! (Ad)pixel
3 Small Financial Software Makers Showing Strong Chart Action
Roku And The 20% Rally That’s About To Start 
Modern Day Options Trading For Beginners! (Ad)pixel
Here’s Why Viking Therapeutics Rose Over 50% on Obesity Drug Data
Don't Be Fooled by These 3 Value Traps
Modern Day Options Trading For Beginners! (Ad)pixel
The Bottom Is In For McCormick & Company
Interactive Brokers: A Better Bet Than Schwab Post-SVB?
S&P 500   3,971.27
DOW   32,394.25
QQQ   307.12
Walgreens Boots Alliance: Blue Chip, High-Yield Turnaround Story
Modern Day Options Trading For Beginners! (Ad)pixel
3 Small Financial Software Makers Showing Strong Chart Action
Roku And The 20% Rally That’s About To Start 
Modern Day Options Trading For Beginners! (Ad)pixel
Here’s Why Viking Therapeutics Rose Over 50% on Obesity Drug Data
Don't Be Fooled by These 3 Value Traps
Modern Day Options Trading For Beginners! (Ad)pixel
The Bottom Is In For McCormick & Company
Interactive Brokers: A Better Bet Than Schwab Post-SVB?
NASDAQ:CUTR

Cutera - CUTR Stock Forecast, Price & News

$24.69
-1.46 (-5.58%)
(As of 03/28/2023 12:00 AM ET)
Add
Compare
Today's Range
$24.41
$26.09
50-Day Range
$24.36
$36.23
52-Week Range
$23.48
$74.38
Volume
498,432 shs
Average Volume
569,226 shs
Market Capitalization
$484.17 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$55.20

Cutera MarketRank™ Forecast

Analyst Rating
Moderate Buy
2.60 Rating Score
Upside/​Downside
108.6% Upside
$51.50 Price Target
Short Interest
Bearish
25.29% of Shares Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.25mentions of Cutera in the last 14 days
Based on 3 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
N/A

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.47 out of 5 stars

Computer And Technology Sector

574th out of 616 stocks

Electromedical Equipment Industry

21st out of 24 stocks


CUTR stock logo

About Cutera (NASDAQ:CUTR) Stock

Cutera, Inc. engages in the provision of laser and energy-based aesthetic systems for practitioners. It operates through the following segments: United States, Japan, Asia excluding Japan, Europe, and Rest of the World. Its products include enlighten, excel HR, excel V+, secret Pro, Juliet, secret RF, and xeo. The company was founded by David A. Gollnick in August 1998 and is headquartered in Brisbane, CA.

Receive CUTR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Cutera and its competitors with MarketBeat's FREE daily newsletter.

CUTR Stock News Headlines

StockNews.com Begins Coverage on Cutera (NASDAQ:CUTR)
Urgent Warning
This was never meant for the general public. But it’s all there in black and white … A frightening plan that gives the Fed the power to track and even control your checking account, including ALL your financial transactions. A pilot test program is already underway. And it’s slated to launch at America’s largest banks as soon as May of this year! So, time to prepare is very short. Fortunately, there are a few key steps you can take to defend yourself …
Cutera® Unveils the Reimagined truBody® Brand
Urgent Warning
This was never meant for the general public. But it’s all there in black and white … A frightening plan that gives the Fed the power to track and even control your checking account, including ALL your financial transactions. A pilot test program is already underway. And it’s slated to launch at America’s largest banks as soon as May of this year! So, time to prepare is very short. Fortunately, there are a few key steps you can take to defend yourself …
Cutera's Charts Are Poised for an Upside Breakout
Cutera: AviClear Key Differentiator, Reaffirm Buy
Cutera Announces Third Quarter 2022 Financial Results
Cutera (CUTR) Reports Q3 Loss, Tops Revenue Estimates
See More Headlines
Receive CUTR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Cutera and its competitors with MarketBeat's FREE daily newsletter.

CUTR Company Calendar

Last Earnings
2/28/2023
Today
3/28/2023
Next Earnings (Estimated)
5/09/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Electromedical equipment
Sub-Industry
N/A
Current Symbol
NASDAQ:CUTR
Employees
461
Year Founded
1998

Price Target and Rating

Average Stock Price Forecast
$51.50
High Stock Price Forecast
$68.00
Low Stock Price Forecast
$33.00
Forecasted Upside/Downside
+123.6%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.60
Research Coverage
5 Analysts

Profitability

Net Income
$-82,340,000.00
Pretax Margin
-31.97%

Debt

Sales & Book Value

Annual Sales
$252.40 million
Book Value
($0.77) per share

Miscellaneous

Free Float
19,046,000
Market Cap
$484.17 million
Optionable
Optionable
Beta
1.58

Social Links


Key Executives

  • David H. MowryDavid H. Mowry
    Chief Executive Officer & Director
  • Rohan SethRohan Seth
    Chief Financial Officer
  • Michael Karavitis
    Chief Technology Officer & Executive VP
  • Charles Guy Thier
    Chief Information Officer
  • Jeremy Livianu
    Secretary, Vice President & General Counsel













CUTR Stock - Frequently Asked Questions

Should I buy or sell Cutera stock right now?

5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Cutera in the last year. There are currently 2 hold ratings and 3 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" CUTR shares.
View CUTR analyst ratings
or view top-rated stocks.

What is Cutera's stock price forecast for 2023?

5 Wall Street research analysts have issued 1 year target prices for Cutera's shares. Their CUTR share price forecasts range from $33.00 to $68.00. On average, they expect the company's stock price to reach $51.50 in the next twelve months. This suggests a possible upside of 108.6% from the stock's current price.
View analysts price targets for CUTR
or view top-rated stocks among Wall Street analysts.

How have CUTR shares performed in 2023?

Cutera's stock was trading at $44.22 at the start of the year. Since then, CUTR shares have decreased by 44.2% and is now trading at $24.69.
View the best growth stocks for 2023 here
.

When is Cutera's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, May 9th 2023.
View our CUTR earnings forecast
.

How were Cutera's earnings last quarter?

Cutera, Inc. (NASDAQ:CUTR) posted its earnings results on Tuesday, February, 28th. The medical device company reported ($0.40) earnings per share for the quarter, missing the consensus estimate of ($0.31) by $0.09. The medical device company earned $67.40 million during the quarter, compared to analyst estimates of $69.52 million. Cutera had a negative net margin of 32.62% and a negative trailing twelve-month return on equity of 489.05%. The firm's quarterly revenue was up 2.7% compared to the same quarter last year. During the same period last year, the company posted ($0.22) earnings per share.

What guidance has Cutera issued on next quarter's earnings?

Cutera issued an update on its FY 2023 earnings guidance on Tuesday, February, 28th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $277.00 million-$292.00 million, compared to the consensus revenue estimate of $300.65 million.

What is David H. Mowry's approval rating as Cutera's CEO?

1 employees have rated Cutera Chief Executive Officer David H. Mowry on Glassdoor.com. David H. Mowry has an approval rating of 100% among the company's employees. This puts David H. Mowry in the top 10% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Cutera own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Cutera investors own include NVIDIA (NVDA), QUALCOMM (QCOM), AbbVie (ABBV), Micron Technology (MU), Gilead Sciences (GILD), Alibaba Group (BABA), DocuSign (DOCU), Pfizer (PFE), Block (SQ) and Twilio (TWLO).

What is Cutera's stock symbol?

Cutera trades on the NASDAQ under the ticker symbol "CUTR."

Who are Cutera's major shareholders?

Cutera's stock is owned by a number of institutional and retail investors. Top institutional shareholders include Millennium Management LLC (7.60%), Gamco Investors INC. ET AL (5.35%), Gamco Investors INC. ET AL (5.35%), Cowen AND Company LLC (3.42%), Eagle Asset Management Inc. (3.30%) and First Light Asset Management LLC (2.89%). Insiders that own company stock include David H Mowry, J Daniel Plants, Joseph E Whitters, Katherine S Zanotti, Rohan Seth and Timothy J Oshea.
View institutional ownership trends
.

How do I buy shares of Cutera?

Shares of CUTR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Cutera's stock price today?

One share of CUTR stock can currently be purchased for approximately $24.69.

How much money does Cutera make?

Cutera (NASDAQ:CUTR) has a market capitalization of $484.17 million and generates $252.40 million in revenue each year. The medical device company earns $-82,340,000.00 in net income (profit) each year or ($4.39) on an earnings per share basis.

How many employees does Cutera have?

The company employs 461 workers across the globe.

How can I contact Cutera?

Cutera's mailing address is 3240 BAYSHORE BOULEVARD, BRISBANE CA, 94005. The official website for the company is www.cutera.com. The medical device company can be reached via phone at (415) 657-5500, via email at ir@cutera.com, or via fax at 415-330-2444.

This page (NASDAQ:CUTR) was last updated on 3/29/2023 by MarketBeat.com Staff